![Kim Smith-Whitley](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Kim Smith-Whitley
Director/Board Member at
Sickle Cell Disease Association of America, Inc.
Profile
Kim Smith-Whitley is currently the Director at Sickle Cell Disease Association of America, Inc. Formerly, Dr. Smith-Whitley was Executive VP, Head-Research & Development at Global Blood Therapeutics, Inc. Dr. Smith-Whitley earned a doctorate from George Washington University.
Kim Smith-Whitley active positions
| Companies | Position | Start |
|---|---|---|
Sickle Cell Disease Association of America, Inc. | Director/Board Member | - |
Former positions of Kim Smith-Whitley
| Companies | Position | End |
|---|---|---|
| GLOBAL BLOOD THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | - |
Training of Kim Smith-Whitley
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
2
1st degree connections
3
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 3 |
|---|---|
George Washington University
 George Washington University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sickle Cell Disease Association of America, Inc. | |
Global Blood Therapeutics, Inc.
 Global Blood Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which provides treatment and care of sickle cell disease for inherited blood disorder | Health Technology |
- Stock Market
- Insiders
- Kim Smith-Whitley
